A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma. Gordon MJ, Dubois S, Bryant B, Ng S, et al. Leuk Lymphoma 2024 Mar 9:1-4. doi: 10.1080/10428194.2024.2326847.

Read + Share

Amedeo Smart

Independent Medical Education

Gordon MJ, Dubois S, Bryant B, Ng S, et al. A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma. Leuk Lymphoma 2024 Mar 9:1-4. doi: 10.1080/10428194.2024.2326847.
PMID: 38459780